Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study
Uzoigwe C, Liang Y, Whitmire S, Paprocki Y (2021) Semaglutide once-weekly persistence and adherence versus other GLP-1 RAs in patients with type 2 diabetes in a US real-world setting
Metabolic reprogramming via an engineered PGC-1 improves human chimeric antigen receptor T-cell therapy against solid tumors
If you notice any abnormalities such as redness or itching at the application site, please do not use it
TK has received speakers honoraria from Sumitomo, Eisai, Janssen, Otsuka, Meiji, MSD, Yoshitomi, and Takeda